RhumbLine Advisers
SBC

RhumbLine Advisers’s SBC Medical Group SBC Stock Holding History

RhumbLine Advisers’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
10,731
+4,284
+66% +$14.5K ﹤0.01% 3757
2026
Q1 		$26.9K Buy
6,447
+1,133
+21% +$4.73K ﹤0.01% 3683
2025
Q4 		$22.9K Sell
5,314
-1,164
-18% -$4.44K ﹤0.01% 3744
2025
Q3 		$28.1K Sell
6,478
-3,167
-33% -$14.3K ﹤0.01% 3740
2025
Q2 		$44.7K Buy
+9,645
New +$38.1K ﹤0.01% 3686

Other funds holding SBC

LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

RhumbLine Advisers's SBC Position: Q2 2026 in Review

RhumbLine Advisers increased its SBC Medical Group (SBC) stake by 66% in Q2 2026, buying an estimated $14.5K and bringing the position to 10,731 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

RhumbLine Advisers first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. The position peaked at $44.7K in Q2 2025. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • RhumbLine Advisers held 10,731 shares of SBC Medical Group worth $33K as of Q2 2026.
  • RhumbLine Advisers bought 4,284 SBC Medical Group shares in Q2 2026, an estimated $14.5K.
  • SBC Medical Group made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3757 holding.
  • RhumbLine Advisers first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • RhumbLine Advisers's SBC Medical Group position peaked at $44.7K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.